Suprachoroidal implant surgery in intractable glaucoma

Palamar, Melis; Ateş, Halil; Oztas, Zafer; Yusifov, Emil

doi:10.1007/s10384-011-0035-1

Cited by 6 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Laser goniopuncture[12] and newer goniosurgical procedures [e.g., trabecular microbypass (iStent),[13] trabectome microelectrocautery,[14] the Eyepass implant,[15] and canaloplasty[16] have been used to enhance conventional outflow pathways. Surgical procedures to augment suprachoroidal outflow include cyclodialysis,[17] suprachoroidal implants,[181920] seton devices,[21] and GMS placement in the suprachoroidal space. [1022] Studies have shown better safety profiles and similar short-term efficacy with these techniques.…”

Section: Discussionmentioning

confidence: 99%

“…However, some studies have shown that fibrosis can cause suprachoroidal devices to gradually fail. [2324] Although there has been some success with suprachoroidal tube implantation,[1819202125] a gradual loss of efficacy may occur. [1819] In one study, ultrasound biomicroscopy revealed that some cases of shunt failure were caused by fibrotic obstruction of the posterior tube lumen.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Modified deep sclerectomy for the surgical treatment of glaucoma

Sharifipour

Yazdani

Asadi

et al. 2019

J Ophthalmic Vis Res

View full text Add to dashboard Cite

Purpose: To report the short-term outcomes of modified deep sclerectomy (MDS) in the management of open angle glaucoma. Methods: This prospective, non-randomized, controlled study included 105 eyes (105 patients) with open angle glaucoma. Eyes were categorized as follows: trabeculectomy (30 eyes), MDS (27 eyes), phacotrabeculectomy (28 eyes), and phaco-MDS (20 eyes). The MDS technique involved removal of a third scleral flap to expose the suprachoroidal space and excision of a trabecular block. A two-site approach was used for combined surgeries. Main outcome measures included intraocular pressure (IOP), number of glaucoma medications, and complications. Treatment success was defined as an IOP of 6–15 mmHg and/or a 30% reduction in IOP. Results: All groups showed significant decrease in IOP and number of medications (both P s < 0.001). The MDS group had a higher IOP (13.9 ± 3.8 vs. 12.4 ± 2.5 mmHg, P = 0.080) and required more medications ( P = 0.001) than the trabeculectomy group at 1 year. The MDS group had a higher baseline IOP than the trabeculectomy group ( P = 0.004) and both the groups showed similar IOP reductions (33.3% vs. 25.7%, P = 0.391). The phaco-MDS and phacotrabeculectomy groups had comparable IOP (13.3 ± 3.1 vs. 12.4 ± 3.1 mmHg, P = 0.354), number of medications ( P = 0.594), and IOP reduction ( P = 0.509) at 1-year follow-up visit. The trabeculectomy and phacotrabeculectomy groups developed more wound leaks ( P = 0.043) and required more bleb needling during the early postoperative period ( P < 0.001). Conclusion: The MDS technique seems to be slightly inferior to trabeculectomy, but when combined with phacoemulsification, is safer and results in similar IOP outcomes.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Modified deep sclerectomy for the surgical treatment of glaucoma

Sharifipour

Yazdani

Asadi

et al. 2019

J Ophthalmic Vis Res

View full text Add to dashboard Cite

show abstract

“…12,13 In contrast to these ab interno procedures, the combined trabeculectomy-cyclodialysis aims to direct flow not only into the suprachoroidal space, but also into the Schlemm canal and the subconjunctival space under a tight scleral trapdoor similar to that used in a trabeculectomy. This pathway is the target for procedures using intraocular microstents.…”

mentioning

confidence: 99%